Cargando…

Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters

AIMS: The Impella is a percutaneous ventricular assist device. The majority of published data describes the 2.5L and 5.0L devices, and little data is available for the newer 3.8L device. We examined the indications and outcomes from our single-centre “real-world” registry at The Queen Elizabeth Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venugopal, Vinod, Spiro, Jon, Zaphiriou, Alex, Khan, Sohail, Townend, Jonathan N., Ludman, Peter F., Doshi, Sagar N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472647/ https://www.ncbi.nlm.nih.gov/pubmed/25515965 http://dx.doi.org/10.1007/s40119-014-0033-8

Ejemplares similares

Contemporary use of excimer laser in percutaneous coronary intervention with indications, procedural characteristics, complications and outcomes in a university teaching hospital
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2021)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Changing trends in the incidence, management and outcomes of coronary artery perforation over an 11-year period: single-centre experience
por: Umar, Hamza, et al.
Publicado: (2022)

Impella 5.0 supported oncological surgery as bridge to LVAD
por: Montisci, Andrea, et al.
Publicado: (2020)

Severe Left Ventricular Failure Unmanageable by Impella 5.0
por: Mano, Akiko, et al.
Publicado: (2023)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
por: Hotta, Naoshi, et al.
Publicado: (2020)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Novel method for transaxillary Impella 5.0 implantation in patients with tortuous arterial anatomy
por: Fisher, Bryant, et al.
Publicado: (2021)

Impella 5.0/5.5 Implantation via Innominate Artery: Further Expanding the Opportunities for Temporary Mechanical Circulatory Support
por: Bertolin, Stephanie, et al.
Publicado: (2022)

Tissue plasminogen activator for axillary Impella 5.0 with heparin-induced thrombocytopenia as a treatment of choice for acute Impella thrombosis: a case report
por: Merino, Elena, et al.
Publicado: (2023)

Left brachial artery: one more way to percutaneous insertion of IMPELLA 2.5L circulatory support for high-risk percutaneous coronary intervention – a case report
por: Sganzerla, Paolo, et al.
Publicado: (2020)

Acute Presentation of Structural Valve Degeneration in a Transcatheter Heart Valve (Sapien XT) at 7.5 Years; Successful Redo TAVR With a Sapien 3 Ultra
por: Doshi, Sagar N., et al.
Publicado: (2020)

Single center experience and early outcomes of Impella 5.5
por: Funamoto, Masaki, et al.
Publicado: (2023)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France
por: Le Guyader, Alexandre, et al.
Publicado: (2021)

Percutaneous Salvage of an Impella Pretzel
por: Mathur, Moses, et al.
Publicado: (2019)

Sacralization of L5 in Radiological Studies of Degenerative Spondylolisthesis at L4-L5
por: Kong, Chae-Gwan, et al.
Publicado: (2008)

L5 radiculopathy caused by L5 nerve root entrapment by an L5-S1 anterior osteophyte
por: Jones, Thomas Louis, et al.
Publicado: (2012)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

A comparative study of L4-L5-S1 and L5-S1 vertebral fusion in high-grade L5-S1 spondylolisthesis
por: Rezvani, Majid, et al.
Publicado: (2021)

Aortic Valve Leaflet Disruption: A Severe Complication of Impella 5.5
por: Ghannam, Alexander D, et al.
Publicado: (2021)

Successful extended use of Impella 5.5 as a bridge to heart transplantation
por: Sharaf, Omar M, et al.
Publicado: (2023)

Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery
por: Sayed, Sameh, et al.
Publicado: (2017)

Predictors of Short-term Survival in Cardiogenic Shock Patients Requiring Left Ventricular Support Using the Impella CP or 5.0
por: Panoulas, Vasileios, et al.
Publicado: (2021)

COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report
por: Valchanov, Kamen, et al.
Publicado: (2020)

Coronary artery bypass grafting under sole Impella 5.0 support for patients with severely depressed left ventricular function
por: Katahira, Shintaro, et al.
Publicado: (2021)

Metasploit 5.0 for Beginners
por: Rahalkar, Sagar
Publicado: (2020)

3L, 5L, What the L? A NICE Conundrum
por: Devlin, Nancy, et al.
Publicado: (2018)

Weaning from Impella and mobilization of Impella patients
por: Bertoldi, Letizia Fausta, et al.
Publicado: (2021)

EQ-5D-5L Portuguese population norms
por: Ferreira, Pedro L., et al.
Publicado: (2023)

Successful use of the Impella Recover LP 5.0 device for circulatory support during off-pump coronary artery bypass grafting
por: Pepino, Paolo, et al.
Publicado: (2014)

Upgrading extra corporeal life support to ECMELLA using Impella 5.0 in rescued INTERMACS 1 patients, lactate level matters!
por: Aludaat, Chadi, et al.
Publicado: (2023)

Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility
por: Roka-Moiia, Yana, et al.
Publicado: (2020)

Serum Potassium Levels of 4.5 to Less Than 5.0 mmol/L Are Associated with Better Vascular Function
por: Maruhashi, Tatsuya, et al.
Publicado: (2022)

Protein L5 is crucial for in vivo assembly of the bacterial 50S ribosomal subunit central protuberance
por: Korepanov, Alexey P., et al.
Publicado: (2012)

Transinnominate Impella 5.5 insertion as a bridge to transplantation in a pediatric patient in refractory cardiogenic shock
por: Bouhout, Ismail, et al.
Publicado: (2022)

Accuracy of the epidural catheter position during the lumbar approach in infants and children: a comparison among L2-3, L3-4, and L4-5 approaches
por: Kim, Yeon A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jqfd6oathug3lget9jmefqvem8